Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare abdominal weight gain and fat distribution in people
taking aripiprazole versus risperidone or quetiapine, to people not taking any of these
antipsychotic medications.